Rehman, Mohammad Ebad Ur
Kulsoom, Afifa
Faraz, Fatima
Mustafa, Biah
Shahid, Abia
Cheema, Huzaifa Ahmad
Maqbool, Shahzaib
Khan, Israr
Hussain, Taimoor
Iftikhar, Ahmed
Awan, Rehmat Ullah
Swed, Sarya
Raza, Shahzad
Anwer, Faiz
Article History
Received: 16 February 2023
Accepted: 27 October 2023
First Online: 31 October 2023
Competing interests
: Faiz Anwer reports personal fees from Bristol Myers Squibb as a speaker and fee from Janssen Pharmaceutical as an advisory board member, this fee was not related to the submitted work. Without receiving direct funding, served as the local principal investigator for Allogene Therapeutics, Celgene, GlaxoSmithKline, and Bristol Myers Squibb; has a consulting or advisory role for Seattle Genetics, Incyte Corporation Speakers’ Bureau, Company: Incyte Corporation; receives travel and accommodations expenses from Seattle Genetics, Incyte; receives honoraria from Incyte, Company: Seattle Genetics; and received research funding from Seattle Genetics, Company: Celgene, Acetylon Pharmaceuticals, Millennium, Astellas Pharma and AbbVie; and reports no other potential conflicts of interest for this work. The other authors report no competing interests.